Szczeklik A - Search Results

1

Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland.

Kasper L, Sladek K, Duplaga M, Bochenek G, Liebhart J, Gladysz U, Malolepszy J, Szczeklik A. Kasper L, et al. Among authors: szczeklik a. Allergy. 2003 Oct;58(10):1064-6. doi: 10.1034/j.1398-9995.2003.00267.x. Allergy. 2003. PMID: 14510727

2

[The frequency of hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs) in the population of adult asthmatics in Poland based on an epidemiological questionnaire].

Kasper Ł, Sładek K, Bochenek G, Duplaga M, Szczeklik A. Kasper Ł, et al. Among authors: szczeklik a. Pneumonol Alergol Pol. 2009;77(5):431-9. Pneumonol Alergol Pol. 2009. PMID: 19890822 Free article. Polish.

3

A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge.

Bochenek G, Nagraba K, Nizankowska E, Szczeklik A. Bochenek G, et al. Among authors: szczeklik a. J Allergy Clin Immunol. 2003 Apr;111(4):743-9. doi: 10.1067/mai.2003.1387. J Allergy Clin Immunol. 2003. PMID: 12704352

4

The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs.

Bochenek G, Nizankowska E, Szczeklik A. Bochenek G, et al. Among authors: szczeklik a. Allergy. 1996 Jan;51(1):16-23. doi: 10.1111/j.1398-9995.1996.tb04544.x. Allergy. 1996. PMID: 8721523

5

Intranasal fluticasone propionate for chronic eosinophilic rhinitis in patients with aspirin-induced asthma.

Mastalerz L, Milewski M, Duplaga M, Nizankowska E, Szczeklik A. Mastalerz L, et al. Among authors: szczeklik a. Allergy. 1997 Sep;52(9):895-900. doi: 10.1111/j.1398-9995.1997.tb01248.x. Allergy. 1997. PMID: 9298173 Clinical Trial.

6

Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma.

Szczeklik A, Nizankowska E, Duplaga M. Szczeklik A, et al. Eur Respir J. 2000 Sep;16(3):432-6. doi: 10.1034/j.1399-3003.2000.016003432.x. Eur Respir J. 2000. PMID: 11028656 Free article.

7

Safety of a specific COX-2 inhibitor in aspirin-induced asthma.

Szczeklik A, Nizankowska E, Bochenek G, Nagraba K, Mejza F, Swierczynska M. Szczeklik A, et al. Clin Exp Allergy. 2001 Feb;31(2):219-25. doi: 10.1046/j.1365-2222.2001.01075.x. Clin Exp Allergy. 2001. PMID: 11251623 Clinical Trial.

8

Testing for aspirin hypersensitivity.

Bochenek G, Niz Ankowska E, Szczeklik A. Bochenek G, et al. Among authors: szczeklik a. Allergy. 2002 Jul;57(7):562-5. doi: 10.1034/j.1398-9995.2002.13447.x. Allergy. 2002. PMID: 12100294 Review. No abstract available.

9

Diagnosis, prevention and treatment of aspirin-induced asthma and rhinitis.

Bochenek G, Bánska K, Szabó Z, Nizankowska E, Szczeklik A. Bochenek G, et al. Among authors: szczeklik a. Curr Drug Targets Inflamm Allergy. 2002 Mar;1(1):1-11. doi: 10.2174/1568010023345011. Curr Drug Targets Inflamm Allergy. 2002. PMID: 14561202 Review.

10

Exhaled eicosanoids following oral aspirin challenge in asthmatic patients.

Sanak M, Kiełbasa B, Bochenek G, Szczeklik A. Sanak M, et al. Among authors: szczeklik a. Clin Exp Allergy. 2004 Dec;34(12):1899-904. doi: 10.1111/j.1365-2222.2004.02123.x. Clin Exp Allergy. 2004. PMID: 15663565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters